Protein Misfolding in Neurodegeneration

A protein's job depends on its shape: a chain of amino acids folds into a specific three-dimensional form, and that geometry — not the amino-acid sequence alone — is what actually does the work. When the fold goes wrong, the consequences are not merely lost activity. Misfolding can expose sticky surfaces normally tucked safely inside the molecule, and those surfaces let copies latch onto one another and clump. Across nearly all neurodegenerative diseases, the same molecular pattern then recurs: a normally-soluble protein misfolds, aggregates into insoluble fibrils, spreads cell-to-cell in a prion-like fashion, and kills the cells in which it accumulates. Amyloid-β and tau in Alzheimer's. α-synuclein in Parkinson's and Lewy-body dementia. Huntingtin in Huntington's. TDP-43 and SOD1 in ALS. Prion protein in Creutzfeldt-Jakob. The diseases are clinically different because each targets different neuron populations; the underlying machinery is suspiciously similar.

The aggregates themselves share a structure. Misfolded chains stack into ordered, self-propagating fibrils called amyloid — a cross-β architecture so stable it resists the cell's ordinary disposal routes, which is part of why it accumulates. Huntington's disease gave the cleanest entry point: an autosomal-dominant CAG-repeat expansion in the huntingtin gene, fully penetrant, with onset typically in middle age and characteristic chorea (involuntary dance-like movements), cognitive decline, and psychiatric features; the misfolded huntingtin kills medium spiny neurons in the striatum. ALS (amyotrophic lateral sclerosis, Lou Gehrig's disease) is heterogeneous: motor-neuron degeneration with TDP-43 pathology in most sporadic cases; SOD1 in 1–2 % (the discovery that founded the field's molecular era in 1993); C9orf72 hexanucleotide repeat expansion as the most common genetic cause, also linked to frontotemporal dementia. Frontotemporal dementias (FTD) — behavioral, semantic, and progressive nonfluent variants, with tau or TDP-43 pathology — overlap clinically and pathologically with ALS. Prion diseases (CJD, kuru, fatal familial insomnia) are the limit case: misfolded prion protein directly catalyzes the misfolding of normal prion protein, producing rapid progression and death within months. The prion-like spread hypothesis (Spillantini, Braak, others, 2010s) generalized this mechanism to all the others — each misfolded protein acting as a template that imposes its own shape on healthy neighbours, the corruption spreading slowly through the tissue along anatomically connected circuits, which provides the long-missing explanation of why each disease has a characteristic anatomical progression. Cells are not defenceless against any of this: chaperones refold or escort damaged proteins, and the proteostasis network — the degradation and clearance machinery that polices the proteome — breaks down and disposes of what cannot be salvaged. But this apparatus weakens with age, the rate of misfolding outruns the rate of repair, and that imbalance is much of why these are largely diseases of later life.